This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Yoon, K H Articles by Sivalingam, P Search for Related Content PubMed PubMed Citation Articles by Yoon, K H Articles by Sivalingam, P Social Bookmarking                   What's this?

High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis

Department of Medicine, National University of Singapore, National University Hospital, Singapore

A Wong

Department of Hematology-Oncology, National University Hospital, Singapore

T Shakespeare

Department of Radiation Oncology, National University Hospital, Singapore

P Sivalingam

Department of Medicine, National University of Singapore, National University Hospital, Singapore

Thrombotic complications are a significant cause of morbidity and mortality in cancer patients. Studies in Caucasian populations have shown that up to one-third of such patients test positive to antiphospholipid antibodies. Our aim was to determine the prevalence and serotypes of antiphospholipid antibodies in an unselected group of Asian cancer patients with thrombosis. All patients with cancer-related thrombosis seen in the Department of Hematology-Oncology and Radiation Oncology were enrolled in this study. The study period was from April 2000 to May 2001. Antiphospholipid antibodies tests were performed, namely lupus anticoagulant screen, anti-cardiolipin antibodies (IgG and IgM) and anti-beta-2 glycoprotein I antibodies (B2 GPI) IgG, IgM and IgA. Thirty-three patients were recruited. There were 14 males and 19 females, with an age range of 35-78 years of age. Of those enrolled, there were 25 Chinese, five Malays and three Indians. The patients had several cancer types: 11 (36.7%) patients had adenocarcinoma as the histological cell type. Of the 33 patients, 75.8% had stage IV disease. Arterial thrombosis was seen in eight patients (24.2%), and venous thrombosis occurred in 29 patients (87.9%). Antiphospholipid antibodies were positive in 60.6% of the patients, of which anti-B2GPI IgA antibody was the most prevalent antiphospholipid present (46.9%). The presence of anti-beta-2 glycoprotein I IgA antibody was associated with strokes, extensive and recurrent venous thrombosis, and coincident arterial and venous thrombosis. A high prevalence of antiphospholipid antibodies (60.6%) was found in Asian patients with cancer-related thrombosis. The presence of antiphospholipid antibodies, particularly anti B2GPI IgA, may identify a subset of cancer patients who are at high risk of developingthrombotic complications, and further studies are warranted.

Key Words: cancer • thrombosis • antiphospholipid antibodies • anti-beta-2 glycoprotein-I IgA

Lupus, Vol. 12, No. 2, 112-116 (2003)
DOI: 10.1191/0961203303lu328oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Qian, F. Xie, A. W. Gibson, J. C. Edberg, R. P. Kimberly, and J. Wu Functional expression of IgA receptor Fc{alpha}RI on human platelets J. Leukoc. Biol., December 1, 2008; 84(6): 1492 - 1500. [Abstract] [Full Text] [PDF]

				I. Paz-Priel, L. Long, L. J. Helman, C. L. Mackall, and A. S. Wayne Thromboembolic Events in Children and Young Adults With Pediatric Sarcoma J. Clin. Oncol., April 20, 2007; 25(12): 1519 - 1524. [Abstract] [Full Text] [PDF]

				G. Endler, C. Marsik, B. Jilma, T. Schickbauer, R. Vormittag, O. Wagner, C. Mannhalter, H. Rumpold, and I. Pabinger Anti-Cardiolipin Antibodies and Overall Survival in a Large Cohort: Preliminary Report Clin. Chem., June 1, 2006; 52(6): 1040 - 1044. [Abstract] [Full Text] [PDF]

				J T Merrill Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus Lupus, November 1, 2004; 13(11): 869 - 876. [Abstract] [PDF]